Pregabalin and Gabapentin – Reclassification of Class C Controlled Drugs

20th March 2019

The drugs pregabalin and gabapentin will be reclassified as class C controlled drugs in the UK from the 1st April 2019.

For users of these drugs, it is important to be aware of the changes this reclassification will make to the prescribing and dispensing processes. It will no longer be legal to supply the drugs through repeat dispensing. The drugs will have to be dispensed within 28 days of a prescription being written and doctors will be required to sign each prescription. This latter requirement may change in the event of an electronic prescription system for controlled drugs being rolled out.

The reclassification does not require changes to the way in which patients store the drugs. NHS England has sent guidance on these changes to all GP practices. If these changes affect you, speak to your pharmacist and GP for more details.

A number of our beneficiary community affected by cardiomyopathy are prescribed either pregabalin or gabapentin primarily for a diagnosed anxiety disorder. Cardiomyopathy UK constantly monitors changes to drug therapies and their provision and will continue to post relevant updates as we receive them.